国产老熟女老女人老人,换着玩人妻hd中文字幕,农民伯伯和乡下妹,男女免费观看做爰视频在线观看

The Fourth Amendment to the Chinese Patent Law: Summary of Key Points

Author:

Published on:

2023-03-13 14:20

The Standing Committee of the National People's Congress passed thedecision of 4th amendment to the Patent Law on October 17th,2020, which will take effect upon June 1, 2021. Please refer to the attachment for a complete table of the amended Chinese Patent Law in comparison with thecurrent version. We have also summarized the key points of thisamendment below for your kind review.

Improved system for protection of design patents:

-       the protection scope of design patents will beexpanded to include designs for the whole or part of a product (Article2, paragraph 4);

-       the terms for design patents will be extended fromten (10) years to fifteen (15) years (Article 42, paragraph 1);and

-       priority may be claimed from prior domestic design patent applications within six (6) months since the prior filingdate (Article 29, paragraph 2).

Newly added non-patentable subject matter:

-       "Substances obtained by means of nucleartransformation" has been amended to "methods of nucleustransformation and Substances obtained by means of nucleartransformation", indicating that both methods and products of nucleartransformation will be non-patentable subject matter (Article 25, paragraph 1).

New legal situation for not losing novelty:

-       “… … where it was first disclosed for thepurpose of public interest when a national emergency or any extraordinary stateof affairs occurs” (Article 24, paragraph 1).

Term compensation for invention patents andespecially for drug patents:

-       for unreasonable delays in the prosecution processof an invention patent, the patentee may request a term compensation forthe patent (Article 42, paragraph 2); and

-       for the time delay caused by the administrativeapproval of new drugs, a term of no more than five (5) years can berequested, where the total effective term of the patent since the approval ofthe new drug shall not exceed fourteen (14) years (Article 42, paragraph3).

Open licensing system of patents:

-       a patentee may voluntarily request the patentadministration department of the State Council to publish a withdrawableopen license statement” which may be accepted by any entity orindividual (Article 50);

-       the patentee may be granted a reduction or exemptionof patent annuities for the time being of patent open licensing (Article51, paragraph 2); and

-       open licensing is limited to non-exclusive licenses only (Article 51, paragraph 3).

Strengthenedenforcement against patent infringements:

-       the statute of limitations for patentinfringement and for disputes over requesting royalties for using a published,pre-grant invention patent application has been amended from two years to three(3) years, in consistency with the latest Civil Procedure Law (Article 74);

-       it has been clarified that thecompensation for patent infringement shall be calculated “according to theactual loss suffered by the right holder due to the infringement or theenrichment gained by the infringer due to the infringement”, which eliminatesthe debates about the priority of the calculation methods (Article 71,paragraph 1);

-       punitive damages may be determined for intentionalinfringements of serious circumstances at one to five times theamount of compensation determined in accordance with the law (Article 71,paragraph 1);

-       the statutory compensation for patentinfringement will be increased from 10,000 ~ 1,000,000 RMB to 30,000~5,000,000 RMB (Article 71, paragraph 2);

-       as for the burden of proof for determiningthe amount of compensation, the court may order the infringer to provideaccounting books and materials related to the infringement, where theinfringer, if failing to provide or provide false materials, may bear adverseconsequences as the court may then refer to the claims and evidences from theright holder to determine the amount of compensation (Article 71, paragraph 4);and

-       as for passing off patents, the upperlimit of administrative fines will be increased from four times to five times the illegal enrichment, or, if the illegal enrichment being zero or lessthan 50,000 RMB, from 200,000 RMB to 250,000 RMB (Article 68).

Patent linkage system for drugs:

-       during the marketing review and approval processof new drugs, the applicant of the marketing authorization, relevant patenteesor interested parties may request the patent administration department of theState Council or the court to confirm whether the drug falls within the scopeof patent protection, where the food and drug Administration may determinewhether to suspend the approval process based on the court’s decision (Article76, paragraphs 1 and 2); and

-       the food and drug administration and thepatent administration departments shall formulate specific measures forimplementing patent linkage of drugs (Article 76, paragraph 3).

Preventingpatent abuse:

-       patentees are required to apply for orenforce patent rights under the principle of good faith and must not abusetheir patent rights (Article 20, paragraph 1); and

monopolies constituted with the abuse of patent rights will be struckunder the Anti-Monopoly Law (Article 20, paragraph 2).
Copyright ? 2018 ADVANCE CHINA IP LAW OFFICE All Rights Reserved.
粵ICP備12081038號(hào)
日木av无码专区亚洲av毛片| 入戏太深动漫未删减在线观看| 亚洲精品无码永久在线观看| 久久精品水蜜桃av综合天堂| 美国式禁忌完整版1一4| 五十六十丰满老熟妇hd| 夜夜躁狠狠躁2021| 诱人的妺妺2中文在线观看车爱| 日本爆乳强伦中文字幕电影| 丰满熟妇岳av无码区hd| 校长办公室岔开腿呻吟| 亚洲日韩VA无码中文字幕| 白天躁晚上躁天天躁2022| 国产97在线 | 中文| 久久婷婷五月综合色精品| 久久久久久av无码免费网站下载| 欧美熟妇av欧差aa片| 色欲色香天天天综合无码WWW| 日本无码成人片在线观看波多| 被粗汉h玩松了尿进去np| 国产精品99精品无码视亚| 军人的粗大(h)拔不出来| 久久久久国色av免费观看性色| 漂亮的女邻居4伦理| 野花日本大全免费观看3中文版| 性20分钟一次| 亚洲中文字幕无码爆乳app| 特级毛片a级毛片100免费播放| av无码精品一区二区三区四区| 日韓丨亞洲丨制服丨亂倫| 总裁攻紧致h粗大学生受小说| 久久精品免视看国产成人不卡| 性熟妇videos另类hd| 伊人久久综合无码成人网| a片免费| 国产欧美久久一区二区三区| 多毛bgmbgmbgm胖在线| 暴虐营妓np宫交| 一区二区乱子伦在线播放| 亚欧色一区w666天堂| 精品人妻无码专区在中文字幕|